Diazoxide
Links shared publicly online about this topic
diazoxide consumer information from Drugs.com
drugs.com — “diazoxide patient information. Detailed drug information for the consumer, includes dosage, diazoxide side effects and more.” View full resource at drugs.com
Most Recently Shared on September 21, 2009 at 6:03 am By:
Comments of using Diazoxide (study 6079875) - eHealthMe.com
ehealthme.com — “The acid blocking effect of the Prevacid prevented the proper absorption of the diazoxide. Her blood sugar levels dropped 20-30 points on Prevacid, requiring a higher dose of the diazoxide. After conferring with the pharmacist and endo, we stopped her Prevacid.” View full resource at ehealthme.com
Most Recently Shared on March 17, 2012 at 4:26 am By:
The acid blocking effect of the Prevacid prevented the proper absorption of the diazoxide. Her blood sugar lev http://t.co/3Bfy9Gqi
In Mice, Common Drug Counteracts Alzheimer’s Changes | Psych Central News
psychcentral.com — “A drug currently used to treat hypoglycemia, and once commonly prescribed in the 1970--™s and 80--™s to help with hypertension, may have a new use: treating” View full resource at psychcentral.com
Most Recently Shared on November 18, 2010 at 1:56 pm By:
News: In Mice, Common Drug Counteracts Alzheimer’s Changes http://bit.ly/dBNG7G
Insulin Levels - TuDiabetes
tudiabetes.org — “I have something called congenital hyperinsulinism (HI) and took diazoxide most of my life to raise blood sugars to acceptable levels. I was told repeatedly gr--” View full resource at tudiabetes.org
Most Recently Shared on February 9, 2011 at 3:51 pm By:
New to diabetes: Insulin Levels: I have something called congenital hyperinsulinism (HI) and took diazoxide mos... http://tud4.us/ij2lAz
Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides
news-medical.net — “Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.” View full resource at news-medical.net
Most Recently Shared on October 25, 2010 at 11:37 am By:
Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides: Essen... http://bit.ly/dCs6HA
Mouse study shows effect of blood pressure drug on Alzheimer's disease, November 15, 2010 News Release - National Institutes of Health (NIH)
nih.gov — “A drug used decades ago to treat high blood pressure has been shown to improve learning and memory in mouse models of Alzheimer's disease, according to a new study by researchers at the National Institute on Aging (NIA), part of the National Institutes of Health. The study found that the drug, diazoxide, acted on nerve cells in the mouse brain in ways that slowed the development of the neurodegenerative disorder. The findings appear in the Nov. 15, 2010, print edition of the Journal of Alzheimer” View full resource at nih.gov
Most Recently Shared on November 15, 2010 at 3:22 pm By:
eyeonfda Pharma and Health Lawyer
Mouse study shows effect of blood pressure drug on Alzheimer's disease - http://ow.ly/39Vi0
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Patricia A. Jackson
If its Health Related. I'm Passionate about it. I've been Nursing for Twenty-nine Years.**.I'll Share All .
-
eHealthMe.com
eHealthMe provides health professionals and patients personalized tools to study millions of drug reports from FDA and community in real time.
-
Psych Central
Psychology and mental health information and support, since 1995. Pages are maintained by Brandi-Ann Uyemura, Associate Editor.
Advertisement
